(Q51588087)

English

Pharmacokinetic, insulinotropic, and glucagonostatic properties of GLP-1 [7-36 amide] after subcutaneous injection in healthy volunteers. Dose-response-relationships.

scientific article published in June 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/7672496

Pharmacokinetic, insulinotropic, and glucagonostatic properties of GLP-1 [7-36 amide] after subcutaneous injection in healthy volunteers. Dose-response-relationships. (English)

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/7672496

pharmacokinetics

1 reference

based on heuristic

inferred from title

Jens Juul Holst

3

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/7672496

author name string

R Ritzel

1

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/7672496

C Orskov

2

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/7672496

M A Nauck

4

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/7672496

publication date

1 June 1995

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/7672496

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/7672496

38

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/7672496

6

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/7672496

720-725

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/7672496

Human glucagon-like peptides 1 and 2 activate rat brain adenylate cyclase

1 reference

https://pubmed.ncbi.nlm.nih.gov/7672496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucagon-like peptide-1, a new hormone of the entero-insular axis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7672496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulinotropic action of glucagonlike peptide-I-(7-37) in diabetic and nondiabetic subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/7672496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification and characterization of glucagon-like peptide-1 7-36 amide-binding sites in the rat brain and lung

1 reference

https://pubmed.ncbi.nlm.nih.gov/7672496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations

1 reference

https://pubmed.ncbi.nlm.nih.gov/7672496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Critical study of the intravenous hyperglycemic triangle in normal man and determination of a "carbohydrate assimilation coefficient"]

1 reference

https://pubmed.ncbi.nlm.nih.gov/7672496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7672496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucagon-like peptide-1 7-36: a physiological incretin in man.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7672496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/7672496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/7672496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucagonlike peptide I (7-37) actions on endocrine pancreas

1 reference

https://pubmed.ncbi.nlm.nih.gov/7672496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biological effects and metabolic rates of glucagonlike peptide-1 7-36 amide and glucagonlike peptide-1 7-37 in healthy subjects are indistinguishable

1 reference

https://pubmed.ncbi.nlm.nih.gov/7672496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gut hormones and diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/7672496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radio-immunoassays for glucagon-like peptides 1 and 2 (GLP-1 and GLP-2).

1 reference

https://pubmed.ncbi.nlm.nih.gov/7672496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/7672496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7672496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33-69) of glicentin

1 reference

https://pubmed.ncbi.nlm.nih.gov/7672496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum

1 reference

https://pubmed.ncbi.nlm.nih.gov/7672496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subcutaneous Injection of the Incretin Hormone Glucagon-Like Peptide 1 Abolishes Postprandial Glycemia in NIDDM

1 reference

https://pubmed.ncbi.nlm.nih.gov/7672496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S001250050344

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/7672496

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/7672496

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51588087&oldid=2143319876"